by The EMEA Home Infusion Services market size is expected to be worth around US$ 12.9 billion by 2030, according to a new report by Vision Research Reports.
The EMEA Home Infusion Services market size was valued at US$ 5,966.8 million in 2020 and is anticipated to grow at a CAGR of 9.3% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39062
Growth Factors
An increase in the number of people suffering from long-term chronic diseases, the growing geriatric population, the growing incidence of hospital-acquired infections, and the cost-effectiveness of home healthcare services are expected to boost the market growth.
The advent of the pandemic favored the growth of the market because home infusion services can be carried out safely, effectively and under the supervision of a physician at a patient’s home without the risk of the patient getting infected. Several illnesses, including immunological deficiencies, cancer, and congestive heart failure, necessitate infusion therapy since oral medications are ineffective. According to the European Society of Cardiology in 2019, there are more than 6 million new cases of cardiovascular diseases in the EU every year, and more than 11 million in Europe as a whole. With about 49 million people in the EU suffering from the condition, the annual cost to EU economies is considerable at EUR 210 billion. As many patients require long-term care, home infusion services are considered to be a more cost-effective option than hospitalization.
The U.K. home infusion services market is expected to witness the highest compound annual growth rate of 9.7% from 2020 to 2028. According to the WHO, in the last few decades, life expectancy in Europe has increased significantly. In many European countries, the proportion of the geriatric population is steadily increasing and is expected to grow even more in the future. This is expected to increase the number of elderly persons who require care. The needs of people suffering from non-communicable diseases, which are the primary causes of disability and mortality, would likewise alter significantly in the next few decades.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 12.9 billion by 2030 |
| Growth Rate | CAGR of 9.3% From 2021 to 2030 |
| Largest Market | Europe |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Services type |
| Regional Scope | Europe, Middle East & Africa |
| Companies Mentioned | OMT GmbH & Co. KG; Licher MT GmbH; Sciensus; Mediq; Hala Healthcare Services; Enayati home healthcare; Orkyn |
Service Type Insights
The clinical monitoring service type segment held the highest revenue share of 30% in 2020. Based on service type, the EMEA home infusion services market is divided into Pharmaceutical preparation and delivery, Patient training, Administration service, Clinical monitoring. The clinical monitoring segment held the largest market share as dosing guidelines for each patient is unique, and the appropriate dose must be customized to both laboratory values and the clinical status of the patient.
Gathering patient data allows the physicians and the nurses to update themselves with the patient’s progress as well as perform appropriate diagnostic procedures and construct a treatment plan accordingly. Clinical monitoring also requires the need for an optimal software program that allows for the efficient collection of clinical data in both breadth and depth.
The pharmaceutical preparation and delivery segment is expected to witness the highest growth over the forecast period. This is because treatment for diseases like cancer is unique for each patient and requires and has to be made based on the condition and severity of the disease. Moreover, many medications have specific intervals and are delivered to patients by Home infusion pharmacists under the consultation of a professional. Pharmacists supervise the dispensing of sterile preparations and delivery activities, as well as clinical monitoring, care planning, and assessment of home infusion patients. Certain medications are temperature sensitive and require adequate storage temperature at the time of delivery and all this is taken care of in Pharmaceutical preparation and delivery service.
Regional Insights
Europe dominated the market and accounted for the largest revenue share of 918% in 2020 and is estimated to witness lucrative growth over the forecast period. European countries like the U.K., Germany, and Switzerland have well-established home care infrastructure. In addition, the presence of publicly funded home care services is contributing to market growth. Moreover, the increasing number of initiatives undertaken by the government to promote patient safety pertaining to home infusion therapy is expected to drive market growth.
Furthermore, the rising geriatric population coupled with the rising prevalence of diseases such as Parkinson’s, arthritis, paralysis is anticipated to increase the demand for home infusion solutions. For instance, in the U.K., one of the important economies in Europe, the geriatric population accounted for nearly 17.8% of the country’s population in 2015 and it is projected to reach approximately 24.6% by 2025.
Key Players
- OMT GmbH & Co. KG
- Licher MT GmbH
- Sciensus
- Mediq
- Hala Healthcare Services
- Enayati home healthcare
- Orkyn
Market Segmentation
- By Service Type
- Pharmaceutical preparation and delivery
- Patient training
- Administration service
- Clinical monitoring
- Regional
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Belgium
- Switzerland
- Russia
- Sweden
- MEA
- South Africa
- Saudi Arabia
- UAE
- Israel
- Egypt
- Europe
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. EMEA Home Infusion Services Market, By Service Type
7.1. EMEA Home Infusion Services Market, by Service Type, 2021-2030
7.1.1. Pharmaceutical preparation and delivery
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Patient training
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Administration service
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Clinical monitoring
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. EMEA Home Infusion Services Market, Regional Estimates and Trend Forecast
8.1. Europe
8.1.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.2. UK
8.2.2.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.3. France
8.2.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.4. Rest of Europe
8.1.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
Chapter 9. Company Profiles
9.1. OMT GmbH & Co. KG
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Licher MT GmbH
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Sciensus
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Mediq
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Hala Healthcare Services
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Enayati home healthcare
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Orkyn
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39062
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
